RHUMBLINE ADVISERS - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 75 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$4,405
-5.7%
2,9370.0%0.00%
Q2 2023$4,669
-97.0%
2,937
-97.5%
0.00%
Q1 2022$156,000
-31.3%
119,210
-7.5%
0.00%
Q4 2021$227,000
-18.9%
128,875
-0.2%
0.00%
Q3 2021$280,000
-37.1%
129,160
+1.7%
0.00%
-100.0%
Q2 2021$445,000
-58.8%
127,050
+16.1%
0.00%0.0%
Q1 2021$1,079,000
-15.8%
109,446
-7.4%
0.00%
-50.0%
Q4 2020$1,282,000
+13.6%
118,241
+7.8%
0.00%0.0%
Q3 2020$1,129,000
-54.3%
109,645
-7.4%
0.00%
-50.0%
Q2 2020$2,472,000
+201.5%
118,373
+41.1%
0.00%
+100.0%
Q1 2020$820,000
-2.7%
83,880
+14.6%
0.00%
+100.0%
Q4 2019$843,000
+113.4%
73,216
+0.9%
0.00%0.0%
Q3 2019$395,000
-54.3%
72,544
-0.2%
0.00%
-50.0%
Q2 2019$864,000
+113.9%
72,669
-5.7%
0.00%
+100.0%
Q1 2019$404,000
+64.9%
77,028
-1.1%
0.00%0.0%
Q4 2018$245,000
-26.2%
77,895
+42.1%
0.00%0.0%
Q3 2018$332,000
+13.7%
54,818
-0.5%
0.00%0.0%
Q2 2018$292,000
+274.4%
55,068
+91.8%
0.00%
Q1 2017$78,000
+34.5%
28,704
+44.7%
0.00%
Q4 2016$58,000
-43.1%
19,833
-19.9%
0.00%
Q3 2016$102,000
+32.5%
24,772
+2.1%
0.00%
Q2 2016$77,00024,2720.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2017
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders